Multifunctional dietary approach reduces intestinal inflammation in relation with changes in gut microbiota composition in subjects at cardiometabolic risk: the SINFONI project

The development of cardiometabolic (CM) diseases is associated with chronic low-grade inflammation, partly linked to alterations of the gut microbiota (GM) and reduced intestinal integrity. The SINFONI project investigates a multifunctional (MF) nutritional strategy's impact combining different...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gut microbes 2025-12, Vol.17 (1), p.2438823
Hauptverfasser: Hornero-Ramirez, Hugo, Morisette, Arianne, Marcotte, Bruno, Penhoat, Armelle, Lecomte, Béryle, Panthu, Baptiste, Lessard Lord, Jacob, Thirion, Florence, Van-Den-Berghe, Laurie, Blond, Emilie, Simon, Chantal, Caussy, Cyrielle, Feugier, Nathalie, Doré, Joël, Sanoner, Philippe, Meynier, Alexandra, Desjardins, Yves, Pilon, Geneviève, Marette, André, Cani, Patrice D, Laville, Martine, Vinoy, Sophie, Michalski, Marie-Caroline, Nazare, Julie-Anne
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The development of cardiometabolic (CM) diseases is associated with chronic low-grade inflammation, partly linked to alterations of the gut microbiota (GM) and reduced intestinal integrity. The SINFONI project investigates a multifunctional (MF) nutritional strategy's impact combining different bioactive compounds on inflammation, GM modulation and CM profile. In this randomized crossover-controlled study, 30 subjects at CM-risk consumed MF cereal-products, enriched with polyphenols, fibers, slowly-digestible starch, omega-3 fatty acids or Control cereal-products (without bioactive compounds) for 2 months. Metabolic endotoxemia (lipopolysaccharide (LPS), lipopolysaccharide-binding protein over soluble cluster of differentiation-14 (LBP/sCD14), systemic inflammation and cardiovascular risk markers, intestinal inflammation, CM profile and response to a one-week fructose supplementation, were assessed at fasting and post mixed-meal. GM composition and metabolomic analysis were conducted. Mixed linear models were employed, integrating time (pre/post), treatment (MF/control), and sequence/period. Compared to control, MF intervention reduced intestinal inflammation (fecal calprotectin,  = 0.007) and endotoxemia (fasting LPS,  
ISSN:1949-0984
1949-0976
1949-0984
DOI:10.1080/19490976.2024.2438823